Later stage / growth

Bicycle Therapeutics

Bicyclic-peptide oncology therapeutics platform

VerifiedPrivate placementCambridge

Companies House: 11036004
GLEIF LEI: 213800XKUI6R7GKC3E43
Latest evidence: 2024-05-23
Evidence snapshot: 2026-08-25

Funding signal7

Dated disclosed rounds · latest 2024-05-23

Procurement signal0

Exact award notices · latest No exact award match

Registry observationMatched

2026-08-01

Regional contextEast

Jun 2026

Signals organise dated evidence; they do not score growth, revenue, creditworthiness or investment performance.

Evidence timeline

11 dated observations

Funding, procurement, registry and identifier records are placed on one chronology. Each row says whether it is a source fact, a record observation or reference metadata; no inferred event is inserted.

2026-08-01
RegistryRecord observation
Status observed: Active
Snapshot evidence only; this row does not claim the status changed on this date.
Companies House ↗exact Companies House number · published projection
2026-02-14
IdentifierReference metadata
LEI record updated
213800XKUI6R7GKC3E43 · registration ISSUED
GLEIF ↗exact Companies House registration-authority identifier (RA000585) · published projection
2024-05-23
FundingSource fact
Private placement
$555M · 6 named investors
Business Wire ↗funding_id joined to resolved canonical company · published
2023-07-12
FundingSource fact
Follow-on offering
$200M
Business Wire ↗funding_id joined to resolved canonical company · published
2021-10-13
FundingSource fact
Follow-on offering
$175M
Gov ↗funding_id joined to resolved canonical company · published
2019-05-22
FundingSource fact
IPO
$64.9M
Gov ↗funding_id joined to resolved canonical company · published
2019-04-15
IdentifierReference metadata
LEI first registered
213800XKUI6R7GKC3E43
GLEIF ↗exact Companies House registration-authority identifier (RA000585) · published projection
2017-10-27
RegistryRegistry fact
Company incorporated
BICYCLE THERAPEUTICS PLC · company 11036004
Companies House ↗exact Companies House number · published projection
2017-06-01
FundingSource fact
Series B
£40M · 7 named investors
Svhealthinvestors ↗funding_id joined to resolved canonical company · published
2014-10-14
FundingSource fact
Series A
£20M
Crunchbase ↗funding_id joined to resolved canonical company · published
2010-04-29
FundingSource fact
Seed
£3.9M · 4 named investors
Finsmes ↗funding_id joined to resolved canonical company · published

Latest disclosed round

Private placement

Date: 2024-05-23
Amount: USD 555m
Sector: Biotech & techbio
Companies House: 11036004
ONS region: East

Evidence status

Directory ready

Identity: Verified
Match: High — exact company number and aligned registered name
Operating status: active
Data origins: Core directory, Live Chris T D1

Capital network

14 linked investors

Lead, participant, lender and other retained roles remain distinct where the source supports them. Every relationship below names its source layer, observation date, match method and publication state.

SR Onelead; participant SV Life Scienceslead Vertex Ventures HClead Atlas Ventureparticipant Cambridge Innovation Capitalparticipant Deep Track Capitalparticipant EcoR1 Capitalparticipant Fairmountparticipant Forbionparticipant Longwood Fundparticipant Novartis Venture Fundparticipant Perceptive Advisorsparticipant RA Capital Managementparticipant SVLSparticipant

Investor	Role	Date	Source	Match / state
SR One	lead; participant	2017-06-01	Finsmes ↗ · Svhealthinvestors ↗	reviewed canonical company and investor alias resolutionsource-linked · published
SV Life Sciences	lead	2010-04-29	Finsmes ↗	reviewed canonical company and investor alias resolutionsource-linked · published
Vertex Ventures HC	lead	2017-06-01	Svhealthinvestors ↗	reviewed canonical company and investor alias resolutionsource-linked · published
Atlas Venture	participant	2017-06-01	Finsmes ↗ · Svhealthinvestors ↗	reviewed canonical company and investor alias resolutionsource-linked · published
Cambridge Innovation Capital	participant	2017-06-01	Svhealthinvestors ↗	reviewed canonical company and investor alias resolutionsource-linked · published
Deep Track Capital	participant	2024-05-23	Business Wire ↗	reviewed canonical company and investor alias resolutionsource-linked · published
EcoR1 Capital	participant	2024-05-23	Business Wire ↗	reviewed canonical company and investor alias resolutionsource-linked · published
Fairmount	participant	2024-05-23	Business Wire ↗	reviewed canonical company and investor alias resolutionsource-linked · published
Forbion	participant	2024-05-23	Business Wire ↗	reviewed canonical company and investor alias resolutionsource-linked · published
Longwood Fund	participant	2017-06-01	Svhealthinvestors ↗	reviewed canonical company and investor alias resolutionsource-linked · published
Novartis Venture Fund	participant	2017-06-01	Finsmes ↗ · Svhealthinvestors ↗	reviewed canonical company and investor alias resolutionsource-linked · published
Perceptive Advisors	participant	2024-05-23	Business Wire ↗	reviewed canonical company and investor alias resolutionsource-linked · published
RA Capital Management	participant	2024-05-23	Business Wire ↗	reviewed canonical company and investor alias resolutionsource-linked · published
SVLS	participant	2017-06-01	Svhealthinvestors ↗	reviewed canonical company and investor alias resolutionsource-linked · published

Funding record

7 disclosed rounds

Open a dated round to move directly between the company, named investors and source publication.

Date	Stage	Amount	Investors	Named sources
2024-05-23	Private placement	$555M	Deep Track Capital · EcoR1 Capital · Fairmount · Forbion · Perceptive Advisors · RA Capital Management	Business Wire ↗
2023-07-12	Follow-on offering	$200M	Not stated	Business Wire ↗
2021-10-13	Follow-on offering	$175M	Not stated	Gov ↗
2019-05-22	IPO	$64.9M	Not stated	Gov ↗
2017-06-01	Series B	£40M	Vertex Ventures HC · Cambridge Innovation Capital · Longwood Fund · Novartis Venture Fund · SR One · SVLS · + 1 more linked	Svhealthinvestors ↗
2014-10-14	Series A	£20M	Not stated	Crunchbase ↗
2010-04-29	Seed	£3.9M	SR One · SV Life Sciences · Atlas Venture · Novartis Venture Fund	Finsmes ↗

Companies House status and filing snapshot

BICYCLE THERAPEUTICS PLC

Exact company-number match from the public register. The retained status is active. Filing dates and SIC codes are registry context, not a credit or investment-quality assessment.

Registered record

Status: Active
Company type: Public Limited Company
Country of origin: United Kingdom
Incorporated: 2017-10-27
Dissolved: Not applicable
Company number: 11036004

Filing context

Accounts category: GROUP
Accounts made up to: 2025-12-31
Next accounts due: 2027-06-30
Confirmation made up to: 2025-08-02
Registry snapshot: 2026-08-01
Live check: Bulk snapshot only

82990Other business support service activities n.e.c.

SourceCompanies HouseDate2026-08-01Matchexact Companies House numberStatepublished projection

Companies House ↗Registry report →

Global legal-entity identifier

213800XKUI6R7GKC3E43

Exact company-number match to the GLEIF golden-copy data. An LEI is an identifier for a legal entity; it is not a credit, risk or investment-quality rating.

GLEIF record

Legal name: BICYCLE THERAPEUTICS PLC
Entity status: ACTIVE
Jurisdiction: GB
Registration status: ISSUED
Last updated: 2026-02-14T21:28:13+00:00
Next renewal: 2027-04-15T21:18:13+00:00

SourceGLEIF LEI2Date2026-08-24Matchexact Companies House registration-authority identifier (RA000585)Statepublished projection

GLEIF record ↗LEI report →

Traceability

Source trail

Funding and investor claims retain named public-source links. This is a dated research snapshot, not a live cap table.

Bicycle Therapeutics

11 dated observations

Status observed: Active

LEI record updated

Private placement

Follow-on offering

Follow-on offering

IPO

LEI first registered

Company incorporated

Series B

Series A

Seed

Private placement

Directory ready

14 linked investors

7 disclosed rounds

BICYCLE THERAPEUTICS PLC

213800XKUI6R7GKC3E43

Source trail